Kidney failure

There are 461 papers on kidney failure in aging research: 28 trials and 262 observational studies in people, 27 in animals, 126 reviews. The newest story, Nov 19, 2026: “Genetic study links blood proteins to kidney disease”.

Disease

461 papers study it186 more mention it92 findings

67 new papers in 30 daysSee all 647 papers on kidney failure

At a glance

Kidney failure is linked with higher mortality after hip fracture in older adults, disability and osteoporosis in human studies. A human trial reports lower kidney failure risk with finerenone, while observational studies in chronic kidney disease link SGLT2 inhibitor use with lower risk and clonal hematopoiesis with higher risk.

92 findings in 74 papers from 2001 to 2026, 19 of them since June 2026

“Finerenone demonstrated consistent reductions in the ≥57% and ≥40% kidney composite outcomes compared with placebo, with no heterogeneity between the frailty subgroups (P values for interaction = 0.93 and 0.76, respectively; Figure ).”
Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index: FIDELITY Post Hoc AnalysisClinical journal of the American Society of Nephrology : CJASN2025doi:10.2215/cjn.0000000700
  • Human trial28
  • Humans262
  • Animals27
  • In silico7

Interventions

6

Intensive blood pressure lowering

no changein humans1RR 0.97

1 study
  1. Intensive blood pressure lowering showed no clear effect on kidney failure in humans With or without chronic kidney disease; compared with standard blood pressure lowering (RR 0.97 per 10-mm Hg reduction, 95% CI 0.84–1.11).

    “Intensive BP lowering did not affect risk of kidney failure (RR per 10-mm Hg reduction, 0.97; 95% CI, 0.84-1.11)”

    ReviewWith or without chronic kidney disease; compared with standard blood pressure lowering

    Intensive vs Standard Blood Pressure Lowering in People With and Without Chronic Kidney Disease: A Systematic Review and Meta-Analysis

    JAMA cardiology

More on Intensive blood pressure lowering

Dietary diversity

downin silico1OR 0.1269

1 study
  1. Dietary diversity protects against kidney failure in silico (OR 0.1269, 95% CI 0.038-0.424).

    “balanced dietary pattern ("Eat all") demonstrated a profound, highly significant causal protective effect against RF”

    In silico

    Diverse diet protects kidneys while carb restriction raises risk

    Medicine

More on Dietary diversity

Angiotensin receptor blockers

no changein humans1

1 study
  1. Angiotensin receptor blockers were not clearly linked with kidney failure in humans (target dose versus below-target dose, veterans with HFrEF, propensity-matched ARB cohort).

    “In the ARB cohort, target-dose had no association with outcomes.”

    Humanstarget dose versus below-target dose, veterans with HFrEF, propensity-matched ARB cohorttarget dose5-yearn = 7,900

    Target-Dose Versus Below-Target-Dose ACE Inhibitors and Lower Risk of Kidney Failure in U.S. Veterans with HFrEF

    European journal of heart failure

More on Angiotensin receptor blockers

SGLT2 inhibitors

downin silico1

1 study
  1. SGLT2 inhibitors decrease kidney failure in silico (2.29 fewer events per 1000 patient years).

    “The same population initiating SGLT2i instead were predicted to have 2.29 fewer renal failure events”

    In silicosimulated patients with type 2 diabetes and high cardiorenal risk, compared with baseline treatmentlifetime

    Sodium–Glucose Cotransporter 2 Inhibitors are Cost-Effective and Dominate Glucagon-Like Peptide-1 Receptor Agonists for Patients with Type 2 Diabetes and High Cardiorenal Risk in Canada

    AHA Scientific Sessions 2025 abstract

More on SGLT2 inhibitors

Fit for the aged classification

downin humans1

1 study
  1. Fit for the aged classification decreases kidney failure in humans (hospitalised geriatric patients) (P < 0.05).

    “Activities of daily living and renal failure improved significantly (P < 0.05).”

    Human trialhospitalised geriatric patients17.4 daysn = 409

    VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classification

    Age and ageing

More on Fit for the aged classification

Angiotensin-converting enzyme inhibitors

downin humans1

1 study
  1. Angiotensin-converting enzyme inhibitors decrease kidney failure in patients with Alport syndrome.

    “Inhibition of angiotensin-converting enzyme slows progression to kidney failure in patients with Alport syndrome”

    Reviewin patients with Alport syndrome

    Feasibility of repairing glomerular basement membrane defects in Alport syndrome

    Journal of the American Society of Nephrology : JASN

More on Angiotensin-converting enzyme inhibitors

Effects

2

Mortality

upin humans1

1 study
  1. Kidney failure is linked with higher mortality in humans.

    “Results highlight the immense burden of kidney failure on mortality and the importance of disease prevention efforts among older adults.”

    Humans

    Using Relative Survival to Estimate the Burden of Kidney Failure

    American journal of kidney diseases : the official journal of the National Kidney Foundation

Survival

downin humans1−36% relative survival

1 study
  1. Kidney failure is linked with lower survival in humans (incident kidney failure) (36% relative survival).

    “The 5-year relative survival was 31% using standard life tables (adjusted for age, sex, race, and year) versus 36% using life tables also adjusted for comorbidities.”

    Humansincident kidney failure5 years

    Using Relative Survival to Estimate the Burden of Kidney Failure

    American journal of kidney diseases : the official journal of the National Kidney Foundation

Upstream

7

Systolic blood pressure

mediatesin humans1

1 study
  1. Systolic blood pressure is linked with kidney failure in humans (Mediation of the relationship between body mass index and renal failure) (7.14% mediated).

    “mediators in the relationship between BMI and renal failure: cystatin C (12.34%), glucose (7.02%), glycated hemoglobin (HbA1c) (6.83%), diastolic blood pressure (6.37%), and systolic blood pressure (7.14%).”

    HumansMediation of the relationship between body mass index and renal failure

    A Mendelian randomization analysis of the causal effect of body mass index on biomarkers and renal failure risk

    Medicine

More on Systolic blood pressure

Diastolic blood pressure

mediatesin humans1

1 study
  1. Diastolic blood pressure is linked with kidney failure in humans (Mediation of the relationship between body mass index and renal failure) (6.37% mediated).

    “five acted as mediators in the relationship between BMI and renal failure: cystatin C (12.34%), glucose (7.02%), glycated hemoglobin (HbA1c) (6.83%), diastolic blood pressure (6.37%)”

    HumansMediation of the relationship between body mass index and renal failure

    A Mendelian randomization analysis of the causal effect of body mass index on biomarkers and renal failure risk

    Medicine

More on Diastolic blood pressure

Glycated hemoglobin

mediatesin humans1

1 study
  1. Glycated hemoglobin is linked with kidney failure in humans (Mediation of the relationship between body mass index and renal failure) (6.83% mediated).

    “five acted as mediators in the relationship between BMI and renal failure: cystatin C (12.34%), glucose (7.02%), glycated hemoglobin (HbA1c) (6.83%), diastolic blood pressure (6.37%)”

    HumansMediation of the relationship between body mass index and renal failure

    A Mendelian randomization analysis of the causal effect of body mass index on biomarkers and renal failure risk

    Medicine

More on Glycated hemoglobin

Glucose

mediatesin humans1

1 study
  1. Glucose is linked with kidney failure in humans (Mediation of the relationship between body mass index and renal failure) (7.02% mediated).

    “five acted as mediators in the relationship between BMI and renal failure: cystatin C (12.34%), glucose (7.02%), glycated hemoglobin (HbA1c) (6.83%), diastolic blood pressure (6.37%)”

    HumansMediation of the relationship between body mass index and renal failure

    A Mendelian randomization analysis of the causal effect of body mass index on biomarkers and renal failure risk

    Medicine

More on Glucose

Cystatin C

mediatesin humans1

1 study
  1. Cystatin C is linked with kidney failure in humans (Mediation of the relationship between body mass index and renal failure) (12.34% mediated).

    “five acted as mediators in the relationship between BMI and renal failure: cystatin C (12.34%), glucose (7.02%), glycated hemoglobin (HbA1c) (6.83%), diastolic blood pressure (6.37%)”

    HumansMediation of the relationship between body mass index and renal failure

    A Mendelian randomization analysis of the causal effect of body mass index on biomarkers and renal failure risk

    Medicine

More on Cystatin C

Short Physical Performance Battery

no changein humans1

1 study
  1. Short Physical Performance Battery was not clearly linked with kidney failure in humans (baseline and time-updated, fully adjusted).

    “neither baseline nor time-updated SPPB was independently associated with kidney failure”

    Humansbaseline and time-updated, fully adjustedn = 3,038

    Lower physical performance links to heart failure and death in CKD

    Clinical journal of the American Society of Nephrology : CJASN

More on Short Physical Performance Battery

Age

no changein humans1

1 study
  1. Age was not clearly linked with kidney failure in humans (ANCA-positive AAV).

    “Kidney failure or kidney recovery outcomes were not significantly different between the younger and elderly groups.”

    HumansANCA-positive AAVn = 70

    Clinical features and outcomes of elderly patients with antineutrophil cytoplasmic antibody-positive vasculitis: a single-center retrospective study

    Kidney research and clinical practice

Associations

62

Mortality

upin humans8RR 4

8 studies
  1. Kidney failure is associated with mortality in humans (Clinically diagnosed Alzheimer's disease).

    “higher mortality hazard was associated with older age, male sex, renal failure, and cancer”

    HumansClinically diagnosed Alzheimer's diseaseMedian follow-up of 112 monthsn = 1,269

    Psychiatric diagnoses did not independently predict survival

    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

  2. Kidney failure is linked with a higher risk of mortality in humans (early surgical site infection after trauma surgery) (RR = 4; 95% CI [1.81-8.85]).

    “severe renal insufficiency (RR = 4; 95% CI [1.81-8.85]), and polymicrobial infection (RR = 3.61; 95% CI [1.12-11.62]) were significantly associated with mortality.”

    Humansearly surgical site infection after trauma surgeryn = 40

    Early surgical site infection after geriatric trauma surgery: mortality, complications, and factors associated with mortality and infection persistence in patients older than 75 years

    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie

  3. Kidney failure is linked with a higher risk of mortality in elderly adults with tuberculosis.

    “mortality was significantly associated with severe renal failure, living in nursing home or long-term care facilities, and weight loss at presentation.”

    Humansin elderly adults with tuberculosis

    Characteristics of tuberculosis in elderly adults: A multicenter French study

    Infectious diseases now

  4. Kidney failure is linked with a higher risk of mortality in patients with circulatory failure (≥10% higher).

    “patients experiencing renal and circulatory failure face a mortality risk that is at least 10% higher than those with circulatory failure alone”

    Humansin patients with circulatory failure

    The Pandora Box from 12 Countries: Who Benefits More from Modern Interventions?

    QeiosPreprint

  5. Kidney failure predicts mortality in hospitalized elderly patients with community-acquired pneumonia (OR 9.46, 95% CI 4.17-21.48).

    “Renal failure (OR, 9.46; 95% CI, 4.17-21.48)”

    Humansin hospitalized elderly patients with community-acquired pneumonia

    Prognostic Factors for Cardiovascular Events in Elderly Patients with Community Acquired Pneumonia: Results from the CAP-China Network

    Clinical interventions in aging

  6. Kidney failure is linked with a higher risk of mortality in humans (osteoporotic hip fracture) (OR: 34.2 [3.25-359.93]).

    “There was higher intra-episode mortality with renal failure (OR: 34.2 [3.25-359.93]; P=.003)”

    Humansosteoporotic hip fracturen = 128

    What risk factors are associated with mortality and readmissions in osteoporotic hip fracture?

    Journal of healthcare quality research

  7. Kidney failure is linked with a higher risk of mortality in humans (elderly hip fracture) (HR 1.44, P < 0.001).

    “renal failure (hazard ratio: 1.44, P < 0.001)”

    Humanselderly hip fracturen = 6,125

    Analysis of the risk factors of mortality in elderly patients with hip fracture using a combined database of medical and long-term care insurance claims data

    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association

  8. Kidney failure predicts mortality in hospitalized patients with CPK elevation >1000 IU/L.

    “Age and renal insufficiency are 2 major predictors for increased mortality in both groups.”

    Humansin hospitalized patients with CPK elevation >1000 IU/Ln = 137

    Elevation of serum creatine phosphokinase in hospitalized patients

    The American journal of the medical sciences

SGLT2 inhibitors

downin humans4OR 0.67

4 studies
  1. SGLT2 inhibitors are linked with a lower risk of kidney failure in adults with CKD receiving specialist nephrology care (OR 0.67 (95% CI 0.52 to 0.85)).

    “SGLT2 inhibitor use was associated with a lower risk of MACE (odds ratio 0.80, 95% confidence interval, 0.71 to 0.91) and KRT (0.67, 0.52 to 0.85).”

    Humansin adults with CKD receiving specialist nephrology caren = 32,856

    Cardiovascular and Kidney Outcomes following Sodium-Glucose Cotransporter 2 Inhibitor Initiation in CKD: A Swedish Nationwide Cohort Study

    Clinical journal of the American Society of Nephrology : CJASN

  2. SGLT2 inhibitors are associated with kidney failure in patients with CKD.

    “Sodium-glucose cotransporter 2 (SGLT2) inhibitor therapy was independently associated with lower risks of death, kidney failure, and cardiovascular events”

    Humansin patients with CKD

    Clinical Implications of Missed CKD Diagnosis in Adults with and without Diabetes Mellitus

    Journal of the American Society of Nephrology : JASN

  3. SGLT2 inhibitors lower the risk of kidney failure in humans (relative effect versus placebo larger in magnitude than with GLP-1-based therapies).

    “They reduce risk of kidney failure and hospitalisation for heart failure, with relative effects on these outcomes versus placebo appearing larger in magnitude than effects achieved with GLP-1-based therapies.”

    Review

    Multiorgan protective therapy for CKM syndrome: the role of GLP-1-based therapies and SGLT2 inhibitors

    European journal of internal medicine

  4. SGLT2 inhibitors lower the risk of kidney failure in humans (diabetic kidney disease / chronic kidney disease).

    “demonstrating consistent reductions in kidney failure and cardiovascular mortality.”

    Reviewdiabetic kidney disease / chronic kidney disease

    Therapeutic Advances in Diabetic Kidney Disease: 30 Years of Evidence and the Rise of the "Fantastic Four" in Nephrology

    Cardiorenal medicine

More on SGLT2 inhibitors

Diabetes mellitus

upin humans2RR 9.1

2 studies
  1. Diabetes mellitus is associated with kidney failure in humans.

    “In octogenarians, hypertension was more strongly associated with postoperative atrial fibrillation, diabetes with renal failure, and cerebrovascular disease with discharge to extended care.”

    Humansfollowing isolated coronary artery bypass grafting; stronger association than in younger patients

    Statewide Trends in Morbidity and Mortality in Octogenarians Undergoing Isolated Coronary Artery Bypass Grafting

    The Annals of thoracic surgery

  2. Diabetes mellitus is linked with a higher risk of kidney failure in humans (RR 9.1 (95% CI 4.8-17.3)).

    “renal failure (RR 9.1 [95%CI, 4.8-17.3])”

    Humans34 years

    Cause-Specific Mortality over 34 Years among Chinese with Newly Diagnosed Diabetes in Da Qing, China

    ADA Scientific Sessions 2025 abstract

More on Diabetes mellitus

Finerenone

downin humans2HR 0.71

2 studies
  1. Finerenone lowers the risk of kidney failure in humans.

    “Finerenone demonstrated consistent reductions in the ≥57% and ≥40% kidney composite outcomes compared with placebo, with no heterogeneity between the frailty subgroups (P values for interaction = 0.93 and 0.76, respectively; Figure ).”

    Human trialn = 12,990

    Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index: FIDELITY Post Hoc Analysis

    Clinical journal of the American Society of Nephrology : CJASN

  2. Finerenone is linked with a lower risk of kidney failure in humans (HR 0.71; 95% CI 0.54-0.93).

    “and renal failure (HR 0.71; 95% CI 0.54-0.93) compared to spironolactone over 1 year”

    Humans1 year

    Finerenone Versus Spironolactone for Cardio-Oncology Patients With Heart Failure: Comparative Outcomes from a Propensity-Matched Analysis

    The American journal of cardiology

More on Finerenone

Osteoporosis

upin humans2OR 2

2 studies
  1. Kidney failure is associated with osteoporosis in humans (dialysis / kidney failure) (73% (T-score ≤-2.5: 65%, fragility fracture: 41%, vertebral fracture: 13%)).

    “CKD-associated osteoporosis was identified in 73% of participants, based on a T-score ≤-2.5 at the hip or lumbar spine (65%), history of fragility fracture (41%) and/or finding of a vertebral fracture (13%).”

    Humansdialysis / kidney failuren = 71

    Therapeutic opportunities for CKD-associated osteoporosis in adults with kidney failure imply screening

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

  2. Kidney failure is associated with osteoporosis in humans (OR 2.0, 95%CI 1.3-3.4).

    “Low BMD was associated with renal failure (OR 2.0, 95%CI 1.3-3.4)”

    Humansfemales

    The yield of routine laboratory examination in osteoporosis evaluation in primary care

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

More on Osteoporosis

Kidney Failure Risk Equation

upin humans1downin humans1

2 studies
  1. kidney failure risk equation predicts kidney failure in humans across eGFR equations, cohorts, multimorbidity groups and time horizons (area under curve 0.86 or higher).

    “Discrimination of KFRE was good (area under curve $\ge $0.86 across eGFR equations in all cohorts, multimorbidity groups and time horizons).”

    Humansacross eGFR equations, cohorts, multimorbidity groups and time horizons2 and 5 years

    Accounting for death improved kidney failure risk predictions

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

  2. Kidney Failure Risk Equation predicts kidney failure in individuals with frailty at 5 years (observed/expected ratio 1.70 (95% CI 1.55 to 1.85)).

    “Kidney failure at 5 years was underestimated in individuals with frailty (observed/expected ratio, 1.70; 95% confidence interval, 1.55 to 1.85).”

    Humansin individuals with frailty at 5 years

    Frailty in Adults with CKD and Validation of the Kidney Failure Risk Equation in Frailty Subgroups

    Clinical journal of the American Society of Nephrology : CJASN

More on Kidney Failure Risk Equation

Male sex

no changein humans1upin humans1HR 1.18–1.28

1 study
  1. male sex is associated with kidney failure in humans after adjustment for biomarker differences (HR 1.18, 95% CI 0.97–1.43).

    “Male sex was no longer associated with higher risk after adjustment for biomarker differences, kidney failure (HR, 1.18; 95% CI, 0.97 to 1.43)”

    Humansafter adjustment for biomarker differencesmales

    Sex-Associated Biomarker Differences in CKD Progression and Mortality

    Clinical journal of the American Society of Nephrology : CJASN

  2. male sex is linked with a higher risk of kidney failure in humans (adjusted for demographics, kidney function, comorbidities, social factors, and medications) (HR 1.28, 95% CI 1.09–1.50).

    “male sex was associated with a higher risk of kidney failure (hazard ratio [HR] 1.28; 95% confidence interval, 1.09 to 1.50)”

    Humansadjusted for demographics, kidney function, comorbidities, social factors, and medicationsmales

    Sex-Associated Biomarker Differences in CKD Progression and Mortality

    Clinical journal of the American Society of Nephrology : CJASN

Household income

upin humans1HR 3.08

1 study
  1. Household income is associated with kidney failure in humans (Household income below $25,000 compared with $200,000 or more) (Adjusted HR 3.08 (95% CI 2.30–4.11)).

    “Lower income was associated with higher mortality and greater risk of all kidney outcomes.”

    HumansHousehold income below $25,000 compared with $200,000 or morekidneyMedian follow-up of 2.76 yearsn = 218,098

    Lower income linked to worsening kidney function and death

    medRxivPreprint

More on Household income

Delay in documented chronic kidney disease diagnosis

upin humans1

1 study
  1. Delay in documented chronic kidney disease diagnosis is associated with kidney failure in humans (patients with chronic kidney disease).

    “Longer time to documented diagnosis and nephrology referral timing were associated with increased risk of kidney failure and cardiovascular events.”

    Reviewpatients with chronic kidney disease

    Delays in screening, diagnosis and monitoring are associated with worse clinical and economic outcomes for patients with chronic kidney disease: a narrative review

    Annals of medicine

More on Delay in documented chronic kidney disease diagnosis

GLP-1 receptor agonists

downin humans1HR 0.44

1 study
  1. GLP-1 receptor agonists are associated with kidney failure in humans (0.1% vs 0.3%; HR 0.44, 95% CI 0.31-0.62).

    “Kidney failure events were also reduced among patients receiving combination therapy (0.1% vs 0.3%; HR 0.44, 95% CI 0.31-0.62).”

    HumansType 2 diabetes and CKD stages 3-4; GLP-1 receptor agonist add-on therapy compared with continued SGLT2 inhibitor monotherapy1 year

    Diabetes drug combination linked to lower death risk

    AHA Scientific Sessions 2026 abstract

More on GLP-1 receptor agonists

All 62

Trial sponsors

Funding

8 grants since 2017

Japan Society for the Promotion of Science¥15.1MNational Institute for Health Research£838KNational Institute on Aging$119K

Contains public sector information licensed under the Open Government Licence v3.0.

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Kidney failure is linked with higher mortality after hip fracture in older adults and with disability in human observational studies. A human trial reports that finerenone lowers kidney failure risk; observational studies link SGLT2 inhibitor use with lower risk in adults with chronic kidney disease receiving specialist nephrology care.

  2. Summary rewritten as its findings changed.

    As it read before

    Kidney failure is linked with higher mortality in human observational studies of older adults with tuberculosis or hip fractures and older patients hospitalized with pneumonia. A human trial reports that finerenone lowers kidney failure risk, while an observational study links physical activity with lower risk.

  3. Summary rewritten as its findings changed.

    As it read before

    Kidney failure is linked with higher mortality in human cohorts, including older adults with hip fractures, tuberculosis or pneumonia, and with disability and osteoporosis. A human trial reports that finerenone lowers kidney failure risk. Observational studies link SGLT2 inhibitor use with lower risk in adults with chronic kidney disease.

  4. Summary rewritten as its findings changed.

    As it read before

    Kidney failure is linked with higher mortality in human studies, including older adults with tuberculosis or hip fractures. A human cohort links retinal age gap with higher kidney failure risk, while a human trial reports that finerenone lowers this risk.

  5. Summary rewritten as its findings changed.

    As it read before

    Human studies associate kidney failure with disability and osteoporosis, and with higher mortality in older adults with hip fractures, tuberculosis or pneumonia. A human trial reports that finerenone lowers kidney failure risk; observational studies link a larger retinal age gap with higher risk, and clonal hematopoiesis with higher risk in people with chronic kidney disease.

Latest

Dec 2025: 12Jan 2026: 40Feb 2026: 22Mar 2026: 28Apr 2026: 8May 2026: 8Jun 2026: 25Jul 2026: 23Aug 2026: 22Sep 2026: 32Oct 2026: 38Nov 2026: 30288 papers in 12 months
Kidney International

Genetic study links blood proteins to kidney disease

Genetic analyses linked 93 of 2,807 blood proteins to kidney outcomes, with 12 holding up under additional checks.Genetic analyses linked 93 of 2,807 blood proteins to kidney outcomes, with 12 holding up under additional checks.

Mendelian randomization · 464,631 peopleKidney
Clinical Journal of the American Society of Nephrology

Semaglutide effects showed no clear racial or ethnic differences

An exploratory randomized-trial analysis included 3,454 participants with race data and 3,388 with ethnicity data, all with chronic kidney disease and type 2 diabetes.An exploratory randomized-trial analysis included 3,454 participants with race data and 3,388 with ethnicity data, all with chronic kidney disease and type 2 diabetes.

Randomized trial · 3,454 peopleSemaglutide
The American Journal of Geriatric Psychiatry

Psychiatric diagnoses did not independently predict survival

A retrospective cohort study of 1,269 people with Alzheimer disease found neither psychiatric diagnoses nor recorded psychiatric drug exposure independently predicted…A retrospective cohort study of 1,269 people with Alzheimer disease found neither psychiatric diagnoses nor recorded psychiatric drug exposure independently predicted survival over a median 112 months.

Cohort · 1,269 peoplePopulations
The Annals of Thoracic Surgery

Heart-test age gap linked to poorer survival after valve surgery

Patients whose estimated age exceeded their actual age by more than five years had higher 30-day death odds than other patients (odds ratio 1.69).Patients whose estimated age exceeded their actual age by more than five years had higher 30-day death odds than other patients (odds ratio 1.69).

Cohort · 5,503 peopleBiomarkers
medRxiv

Lower income linked to worsening kidney function and death

Household income below $25,000, versus $200,000 or more, was linked to sustained kidney decline with an adjusted hazard ratio of 3.57.Household income below $25,000, versus $200,000 or more, was linked to sustained kidney decline with an adjusted hazard ratio of 3.57.

Preprint: cohort · 218,098 peopleKidney

See all 647 papers on kidney failure